Menu

CME Corner

Active Programs

Multidisciplinary Care of Patients with Relapsed/Refractory Multiple Myeloma

The treatment landscape for multiple myeloma (MM) is rapidly evolving. This activity will examine tailored treatment approaches for patients with relapsed/refractory multiple myeloma. ...

  • Online Presentation Online Presentation
  • ACCME

Dialogue with the Experts: Strategies for Improving Interstitial Lung Disease Diagnosis and Treatment

An early and accurate diagnosis of ILD and its specific type is vital to directing therapy and monitoring disease course and therapeutic response, but these conditions are often mischaracterized and a correct diagnosis is very often delayed. This activity will examine recent advances in ILD diagnosis and treatment. ...

  • Video Roundtable Video Roundtable
  • ACCME

Primary Care Perspectives: Recognizing and Managing Opioid-Induced Constipation

Constipation is a common adverse effect resulting from opioid medications: an estimated 40% of patients receiving opioids to manage noncancer pain experience opioid-induced constipation (OIC). Unlike other adverse effects of opioids, such as nausea, the severity of OIC rarely diminishes over time and is often dose limiting. As a result, OIC can have a significant negative impact on activities of d ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

The Evolving Migraine Paradigm: Tailoring Treatment

Migraine is underdiagnosed and frequently misdiagnosed, undertreated, and/or improperly managed, leading to reduced health-related quality of life, increased risk of psychiatric and medical comorbidities, and increased headache-related burden. This activity will improve clinicians' ability to manage migraine in adult patients, resulting in improved outcomes for patients. ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

The Evolving Migraine Paradigm: Improving Diagnostic Accuracy

Migraine is underdiagnosed, frequently misdiagnosed, undertreated, and/or improperly managed, leading to reduced health-related quality of life, increased risk of psychiatric and medical comorbidities, and increased headache-related burden. This activity will improve clinicians' ability to diagnose migraine, resulting in improved outcomes for patients. ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Psoriatic Arthritis: Understanding the Patient Experience to Improve Patient Satisfaction and Outcomes

The validated tools to assess PsA severity often do not capture what patients consider to be most important/challenging about their disease. To effectively engage patients when developing treatment plans, clinicians need information about the patients’ individual experiences with, perceptions of, and beliefs about PsA. In this “Rate the Quality” activity, you will meet three patients and rate the ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Updates on Molecular Testing in NSCLC

Oncologists have new options when treating advanced NSCLC. The use of molecular profiling to define subgroups of patients most likely to experience clinical benefit from novel targeted therapies has been endorsed by both ASCO and the National Comprehensive Cancer Network (NCCN).This activity will examine the role of molecular biomarkers in patients with advanced NSCLC. ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Identifying and Managing Patients with IBD at Risk for Progressive Disease

IBD is a chronic gastrointestinal condition characterized by recurring disease activity. Treatment approaches for IBD vary depending on disease type and severity and patient risk profile. An accurate diagnosis combined with severity and risk assessments at appropriate intervals are essential for optimal management of IBD. Despite guidance from AGA and ACG, however, clinicians demonstrate considera ...

  • Online Presentation Online Presentation
  • ACCME

Patient-Centered Care in Advanced Prostate Cancer

Recommended treatment options for prostate cancer vary based on disease severity and life expectancy, with traditional approaches including active surveillance, surgery, radiation therapy, chemotherapy, and androgen deprivation therapy (ADT). Prostate cancer that progresses despite ADT is known as castration-resistant prostate cancer (CRPC). Until recently, the standard of care for CRPC patients w ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Clinical Insights in Pediatrics: Improving Asthma Control by Optimizing Pharmacotherapy, Monitoring, and Patient Education

Millions of children and their families are affected by asthma, the most common chronic illness of childhood and the third leading cause of hospitalization among children under the age of 15. Pediatricians and pediatric nurse practitioners are uniquely positioned to care for children and adolescents with asthma, as they are heavily involved in the assessment, management, and follow-up of these pat ...

  • i-Newsletter i-Newsletter
  • ACCME
  • NAPNAP

Advances in Severe Asthma Management: The Role of Biologics for Severe Asthma

Severe asthma is a heterogeneous condition that consists of multiple phenotypes. Roughly 10% of individuals with asthma experience poor control because they suffer from an underlying severe asthma pathophysiology characterized by airway inflammation resistant to conventional therapy. This activity will examine treatments tailored to various phenotypes. ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Advances in Severe Asthma Management: Understanding the Immunopathology of Uncontrolled Asthma

While poor asthma control is frequently attributed to poor adherence to prescribed medications and/or recommended environmental restrictions, 5% to 10% of patients experience poor control because they suffer from an underlying severe asthma pathophysiology characterized by airway inflammation resistant to conventional therapy. Severe asthma is a heterogeneous condition that consists of multiple ph ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Motivational Interviewing to Support Shared Decision Making in MS
First Question: Should I Start Treatment?

This activity, the first in a 3-part series focused on shared decision making and patient-centered care in MS, will examine the practice of motivational interviewing (MI) and how it can help clinicians prompt patients to think about their diagnosis and therapeutic options. The management of MS is increasingly challenging due to the wide variation in the clinical course for each patient, an increas ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ANCC

Shared Decision Making in Selecting Initial MS Disease-Modifying Therapy
Next Question: Which Disease-Modifying Therapy Should I Try First?

This activity, the second in a 3-part series focused on shared decision making and patient-centered care in MS, will examine the differences in MS disease-modifying therapies (DMT) and provide guidance for working together with patients to select appropriate first-line treatment. ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ANCC

Shared Decision Making at the Crossroads: Adjusting MS Therapy Next Question: When Is it Time to Adjust Therapy?

This activity, the third in a 3-part series focused on shared decision making and patient-centered care in MS, will examine how to assess outcomes of DMT therapy from both patient and clinician perspectives, as well as practical strategies for working with patients to adjust therapy when necessary. ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ANCC

Clinical Insights in Pediatrics: Diagnosing and Managing Pediatric Epilepsy

In the United States, an estimated 460,000 children have active epilepsy, and approximately 750,000 children have a history of epilepsy. Epilepsy is a complex disorder that requires careful monitoring and management. Newer pharmacologic options for the treatment of focal and generalized seizures may provide more effective treatment options in the pediatric population. In addition to managing epile ...

  • i-Newsletter i-Newsletter
  • ACCME
  • NAPNAP

Assessing Psoriatic Arthritis Severity, Setting Goals, and Monitoring Progress

Psoriatic arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis. An estimated 7.5 million Americans have psoriasis, and an estimated 30% to 40% of individuals with psoriasis also develop PsA. Symptoms of PsA include fatigue, pain and inflammation in joints, and potentially progressive joint damage. Despite the availability of a variety of treatment options, many patients wi ...

  • Online Presentation Online Presentation
  • ACCME

Improving Patient Satisfaction with Psoriatic Arthritis Treatment

An estimated 7.5 million Americans have psoriasis, and an estimated 30% to 40% of individuals with psoriasis also develop psoriatic arthritis (PsA). Despite the availability of a variety of treatment options, many patients with PsA continue to experience suboptimal outcomes. This activity will examine tailoring therapy to maximize patient satisfaction. ...

  • Online Presentation Online Presentation
  • ACCME

Integrating Recently Approved Therapies into Psoriatic Arthritis Treatment Plans

Despite the availability of a variety of treatment options, many patients with psoriatic arthritis (PsA) continue to experience suboptimal outcomes. Recent research, however, has resulted in several newly approved and investigational agents that are likely to improve patient outcomes. This activity will examine recently approved and investigational therapies and their potential integration into tr ...

  • Online Presentation Online Presentation
  • ACCME

IBD Diagnosis and Management: Untangling the Complexities

Inflammatory bowel disease (IBD), which comprises ulcerative colitis (UC) and Crohn’s disease (CD), is a complex condition that can be difficult to identify and treat. Carefully tailoring and monitoring care is essential because therapeutic goals and strategies differ by disease severity. New data available to clinicians are revising the management paradigm for IBD as well as the definition of dee ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Optimizing Asthma Control: Individualizing Therapy

This activity is the second in a 2-part interactive series titled "Point of Care Clinical Decisions in Asthma Management." Approximately 25.7 million Americans suffer from asthma, a chronic inflammatory disorder of the airways, resulting in recurrent episodes of airflow limitation, mucus production, and cough. Despite many effective therapies and recent advances, many patients continue to experien ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Assessing Asthma Severity: A Self-Assessment and Clinical Overview

This activity is the first in a 2-part interactive series titled "Point of Care Clinical Decisions in Asthma Management." Approximately 25.7 million Americans suffer from asthma, a chronic inflammatory disorder of the airways, resulting in recurrent episodes of airflow limitation, mucus production, and cough. Despite many effective therapies and recent advances, many patients continue to experienc ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Clinical Insights in Pediatrics (an i-Newsletter series)

Clinical Insights in Pediatrics (an i-Newsletter series) ...

  • Series
  • ACCME
  • NAPNAP

Expired Programs

A Case Study in Monitoring and Managing Response and Resistance in CML

Chronic myeloid leukemia (CML) is a myeloproliferative disorder of the bone marrow, accounting for 15% of adult leukemias. Targeted therapy with tyrosine kinase inhibitors (TKIs) has dramatically improved 10-year overall survival for patients with CML from 20% to 80%-90%. To determine the best treatment approach for patients with CML, clinicians must thoroughly understand how to monitor treatment ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Achieving Optimal Outcomes in Patients With Inflammatory Bowel Disease

NOTE: This activity was presented as a live visiting faculty grand rounds series beginning on September 22, 2015. Participants who received credit for attending any of the live presentations are not eligible to receive credit for this online release. IBD is a chronic progressive inflammatory disorder of the GI tract, which includes Crohn’s disease (CD) and ulcerative colitis (UC). CD and UC ar ...

  • Online Presentation Online Presentation
  • ACCME

Acute Heart Failure: Current Best Practices, Ongoing Challenges, and Future Directions

Each year, more than 1 million individuals are hospitalized for heart failure (HF). Within the spectrum of HF, acute heart failure (AHF) represents a distinct challenge to clinicians. Diagnosis of AHF is often delayed because of the complex characteristics of the condition. The heterogeneous nature of AHF patients and the presence of comorbid conditions can make it difficult for clinicians to reco ...

  • Online Presentation Online Presentation
  • ACCME

Diagnosis of PsA: Achieving an Accurate Assessment

Approximately 30% to 40% of people with psoriasis will also develop psoriatic arthritis (PsA), a painful and potentially disfiguring condition that remains underdiagnosed. Symptoms include fatigue, joint inflammation, and potentially progressive joint damage. This activity will examine the considerations for assessment and diagnosis of PsA. ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Improving Outcomes in Psoriasis: Exceeding Treatment Goals and Patient Expectations

This activity will address the management of psoriasis, including setting psoriasis treatment goals and monitoring treatment response to determine when adjustments to therapy are needed; developing tailored, evidence-based treatment regimens for individual patients; engaging patients in shared decision making for improved patient satisfaction; and considering clinical advances while developing tre ...

  • Online Presentation Online Presentation
  • ACCME

Improving Patient Outcomes in Chronic Myeloid Leukemia: Monitoring and Managing Response and Resistance

NOTE: This activity was presented as a live visiting faculty grand rounds series beginning on October 29, 2015. Participants who received credit for attending any of the live presentations are not eligible to receive credit for this online release. Chronic myeloid leukemia (CML) is a myeloproliferative disorder of the bone marrow, accounting for 15% of adult leukemias. Targeted therapy with ty ...

  • Online Presentation Online Presentation
  • ACCME

Individualizing Treatment Plans for Older Adults with T2DM

Approximately 26% of adults over age 65 in the US (11.2 million people) have diabetes. This is a heterogeneous population that includes individuals residing independently in communities, in assisted living, and in skilled nursing facilities. Management of diabetes in older adults should be carefully tailored, taking into account these variables. All members of the care team, including physicians, ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ACPE
  • ANCC

Management of Psoriatic Disease: Care and Ongoing Monitoring

Psoriatic arthritis (PsA) is underdiagnosed and undermanaged in the United States, and comorbidities that are often associated with PsA are sometimes overlooked. Many patients with PsA experience a significant emotional and physical impact from this condition despite an increase in options for successful treatment. This activity will examine the importance of early recognition and the consideratio ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Opioid-Induced Constipation: Improving Outcomes With Individualized, Evidence-Based Treatment

This activity will review the safety and efficacy of available therapies to prevent and treat opioid-induced constipation. It will also examine strategies for optimizing treatment selection and adjusting therapy when necessary to help patients achieve their treatment goals and improve their overall quality of life. ...

  • Reach MD / podcast Reach MD / podcast
  • ACCME

Perspectives on the Care of Older Adults with T2DM: A Multidisciplinary Discussion

This activity features an engaging multidisciplinary faculty discussion about special considerations in the care of older adults with T2DM. Many older adults with T2DM are experiencing negative health consequences that could be prevented or improved with optimal evidence-based care. This is a heterogeneous population that includes individuals residing independently in communities, in assisted livi ...

  • Video Roundtable Video Roundtable
  • ACCME
  • ACPE
  • ANCC

Preventing Stroke in Atrial Fibrillation

Individuals with atrial fibrillation (AF) have a 4 to 5 times greater risk for ischemic stroke and tend to experience more serious strokes than those without AF. Although most strokes related to AF could be prevented with appropriate anticoagulation therapy, many patients are not receiving it. The goal of this activity is to help clinicians evaluate and optimally manage stroke risk in their patien ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Progress Against Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial pneumonia, and its diagnosis and management remain a challenge in clinical practice. An expanding body of research on the pathogenesis of IPF, however, is leading to the identification of new therapeutic targets, and best practices are evolving with the emergence of new data and new therapies. This activity, which featu ...

  • Video Roundtable Video Roundtable
  • ACCME

Stroke Prevention in Atrial Fibrillation: Current Evidence for Tailoring Antithrombotic Therapy

NOTE: This activity was presented as a live visiting faculty grand rounds series beginning on August 20, 2015. Participants who received credit for attending any of the live presentations are not eligible to receive credit for this online release. Nonvalvular atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice and afflicts more than 3 milli ...

  • Online Presentation Online Presentation
  • ACCME
  • ANCC

Targeting B-Cell Lymphomas: The Latest Updates in Therapies, Practice Strategies, and Clinical Research

The standards of care in treatment for non-Hodgkin lymphomas (NHL) are evolving as new therapies receive FDA approval and new evidence provides insight into optimal evidence-based approaches. Several key cellular pathways that drive malignant B-cell development have recently been identified and validated, leading to the development of therapies targeting these pathways. Agents targeting the B-cell ...

  • Online Presentation Online Presentation
  • ACCME

Team-Based Approaches to Enhancing Care for Older Adults With T2DM

A collaborative and engaged style of care planning generally provides the best results for patients. Physicians, NPs, PAs, pharmacists, nurses, and others who care for and support older adults with type 2 diabetes (T2DM) can be most effective working in a team, especially when managing individuals with multiple chronic problems. This activity examines the key features of a holistic, relationship-b ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ACPE
  • ANCC

Updates in the Management of COPD: Comorbidities and COPD

This activity will help clinicians achieve greater competency in the management of COPD and its myriad comorbidities. ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Updates in the Management of COPD: Diagnosis and Management

This activity will help clinicians achieve greater competency in accurately diagnosing COPD, assessing disease severity, and optimizing the use of nonpharmacologic and pharmacologic interventions in tailored COPD treatment plans. COPD is a slowly progressive respiratory disease characterized by airflow limitation that is not fully reversible. Manifestations of COPD include dyspnea, poor exercise t ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Updates in the Management of COPD: Managing Exacerbations

This activity will help clinicians achieve greater competency in managing exacerbations of COPD and optimizing the use of nonpharmacologic and pharmacologic interventions in tailored COPD treatment plans. ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Using GLP-1 Receptor Agonists to Optimize Glycemic Control

The management of T2DM remains a major challenge as many patients continue to struggle with achieving glycemic control. Glucagon-like peptide 1 (GLP-1) receptor agonists, one of the newer drug classes for the treatment of T2DM, have been shown to be safe and effective in improving glycemic control. This activity will examine the use of GLP-1 receptor agonists in clinical practice, including long-t ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Using GLP-1 Receptor Agonists to Reduce Cardiovascular Risk

The management of T2DM remains a major challenge as many patients continue to struggle with achieving therapeutic targets, including control of A1c levels, LDL cholesterol, and blood pressure. Glucagon-like peptide 1 (GLP-1) receptor agonists, one of the newer drug classes for the treatment of T2DM, may offer beneficial effects on cardiovascular risk factors. This activity will examine the use of ...

  • Mobile + Online on QuantiaMD
  • ACCME
Main Menu
EDITOR'S PICKS